Pharmacovigilance UK & EU 2024

34th Pharmacovigilance UK & EU 2024 is organized by Virtue Insight and will be held from Jan 30 - 31, 2024 at Sheraton Skyline Hotel London Heathrow, London, England, United Kingdom.

Description:
We have sponsorship opportunities available for the event, which gives you an opportunity to speak/exhibit, and create brand awareness. Here you can have a dedicated networking time, meet the leading international vendors and expand your knowledge of the latest business models. 

KEY SPEAKERS:

·        KHAUDEJA BANO, Vice President, Combination Product Quality, Amgen

·        FABIO DE GREGORIO, Vice President, Head of Drug Safety Europe, Shionogi Europe

·        SUMIT MUNJAL, Vice President, Global Patient Safety Evaluation, Takeda Pharmaceuticals

·        TANUJA HALADY, Senior Medical Director, Head of GPS Oncology Group III, Merck KGaA

·        GEORGIA GAVRIILIDOU, Associate General Counsel (Executive Director), Amgen

·        JOHN SOLOMON, Head of Pharmacovigilance - UK & Ireland, Sanofi

·        YVONNE NANCIU, Country Head Pharmacovigilance, Bayer

·        PAV RISHIRAJ, Director, Head of Pharmacovigilance, Ipsen

·        MIJAL CHAVDA, Senior Director, Global Head of GxP Inspections & GVP Quality, Kyowa Kirin

·        RAJ BHOGAL, Sr. Director, R&D Business Strategy & Operations, Jazz Pharmaceuticals

·        VALENTINA MANCINI, Senior Director Pharmacovigilance, QPPV, Shionogi Europe

·        MICHAEL BEAN, Senior Director, BioResearch Regulatory Compliance, Johnson & Johnson

·        ALINA TUDOR, Senior Director, Pharmacovigilance, Kyowa Kirin International

·        HUMAIRA QURESHI, President, Qinecsa Solutions

·        PETAR GJORGIEV, Medical Director & Safety Risk Lead, Pfizer

·        SABINE POLTERMANN, Head of Country Patient Safety Switzerland, Bristol-Myers Squibb

·        RISHI CHOPRA, Executive Director, Global Head of PV Regions, CSL Behring

·        JUDY BARRETTO, Global Process Owner, Signal Management Director, Roche

·        EVI MATHIOU, Legal, Compliance & Quality Director, Novo Nordisk

·        TEA BABIC, Director, PV Audits & Inspections, Teva

·        ZINA SADEQ, Director, Regional PV & Alliance Management, Amicus Therapeutics

·        MARIANA CALZADA MIJANGOS, CHC Country Safety Head, Sanofi

·        TERESA SARAGOCA, Director, Regulatory Affairs & Technical Manager, ITALFARMACO

·        DNYANESHWAR SANAP, EU/UK QPPV, Head Regional Pharmacovigilance, Glenmark

·        SIMON ASHWORTH, Head of Pharmacovigilance and Medical Safety, ONO PHARMACEUTICAL

·        SUZANNE FONCIN, Head of Safety Writing, UCB

·        GURPREET SINGH, VP, Managing Director Integrated Safety, IQVIA

·        CINTHYA GALICIA QUINTANAR, Senior Manager, Country Safety Lead, Pfizer

·        MARIANNE MOUNIR, Senior Global System Auditor, Bayer

·        JOHN POUSTIE, EMEA Director Pharmacovigilance and UK QPPV, Haleon

·        MARIJA BRIEDE, Head of Pharmacovigilance, QPPV, Grindeks

·        UPDESH DOSANJH, Practice Leader, Technology Solutions, IQVIA

·        DARIUS-JEAN NAMDJOU, Head of Regulatory Affairs & Pharmacovigilance, Immunic Therapeutics

·        FATIMA YOUSEF GHETHAN, Quality Culture & Implementation Manager, Executive Administration of Quality & Patient Safety, Makkah Healthcare Cluster (UAE)

·        DANIELA DI COSMO, Senior Safety Advisor, Global Safety, Ferring Pharmaceuticals

·        VERONICA SANCHEZ-BARRIGA BORRERO, Global PV QA Compliance Manager, ITALFARMACO

·        DIMITRIS ZAMPATIS, Global Program Safety Lead, Sandoz

·        GAURI UTTURKAR, Patient Safety Physician, UCB

·        MARIE-CLAIRE WILSON, Engagement Manager, Axian Consulting

·        LIZANNE PISTORIUS, Senior Manager Global Patient Safety Operations, QMS & RMP, Nestlé / Aimmune Therapeutics

·        ENIKO BARTA-KONDAS, Head Global PV Operations, Gedeon Richter

·        KAPIL BHUTADA, Senior Director, Inozyme Pharma

·        ALEXANDER ROUSSANOV, International Partner, Life Sciences and Privacy, Arnold & Porter

Plus more joining soon

KEY THEMES DISCUSSED:

·        Market trends and the way forward - Future of pharmacovigilance

·        Pharmacovigilance: What comes next for the industry?

·        Current Challenges & Opportunities in Pharmacovigilance - Pragmatic Approaches

·        Collaboration among all the parties (industry, regulators, patients, healthcare professionals, WHO, etc

·        Rethinking relationship between Sponsor, Site, CRO & Patients – Working together

·        Impact of Technology (AI / ML)

·        Quality, Safety, Signal Detection - Traditional and innovative approaches

·        Outsourcing Pharmacovigilance: Benefits of a Specialized Safety Partner

·        Pharmacovigilance & Risk Management - Current Status & Future Needs

·        Plan, develop and implement the PV Audit strategy plan

·        Medical devices – Increasing safety perspective

·        Prioritising patients in quest to achieve Patient Safety

·        Regulatory - EU and UK Regulations & Guidelines in Pharmacovigilance

·        Best practices & the way forward

·        Be part of a major networking opportunity

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.

SPONSORS:
Silver Sponsor - Qinecsa Solutions, IQVIA Technologies

Bronze Sponsor - Brookwood Global, PharmaLex, DrugCard

Panel Partner - Freyr Solutions, Axian Consulting